# ICS/LABA Adherence and COPD Exacerbation

> **NCT02446041** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 10000 (actual)

## Conditions studied

- Pulmonary Disease
- Chronic Obstructive

## Interventions

- **OTHER:** Non-Interventional Study

## Key facts

- **NCT ID:** NCT02446041
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-05
- **Primary completion:** 2015-10
- **Final completion:** 2015-10
- **Target enrollment:** 10000 (ACTUAL)
- **Last updated:** 2016-10-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02446041

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02446041, "ICS/LABA Adherence and COPD Exacerbation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02446041. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*